Roussel Delma Pharmaceuticals

Roussel Delma Pharmaceuticals is a global pharmaceutical manufacturing and development company with headquarters in Edinburgh, United Kingdom, and New York, USA. The company specializes in the production of Active Pharmaceutical Ingredients (APIs), excipients, and finished dosage forms (FDF) across various therapeutic areas, including oncology, cardiovascular health, and neurology. Operating as a Contract Development and Manufacturing Organization (CDMO), Roussel Delma provides end-to-end solutions such as sterile liquid formulation, solid-state characterization, and scale-up capabilities for both small molecules and biologics. Additionally, the company has a significant presence in the medical device sector, manufacturing products like trocar catheters, drainage sets, and electrosurgical instruments. With over a decade of industry experience, Roussel Delma is recognized for its commitment to regulatory compliance and high-quality pharmaceutical solutions serving a global market.